shutterstock_174194300 - Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Phase IV trial results show Eylea dosing schedule improvement is possible

shutterstock_174194300
Bayer’s recently released results from the trial have shown that there can be greater flexibility in the treatment regimen for patients with macular degeneration using Eylea. Credit: Image Point Fr / Shutterstock.